论文部分内容阅读
目的:观察卡马西平治疗快速型心律失常的疗效。方法:76例病人(男性36例,女性40例;年龄44±s21a),其中,室性早搏(VPB)34例,房性早搏(APB)28例,阵发性室上性心动过速(PSVT)14例,经卡马西平0.1g,po,tid,共10d治疗。治疗前后采用24h动态心电图记录观察该药的疗效。结果:VPB,APB和PSVT有效率分别为74%,79%和93%,不良反应少。结论:小剂量卡马西平(0.3g/d)确为安全、有效的抗心律失常药物,但不宜加大剂量
Objective: To observe the effect of carbamazepine on tachyarrhythmia. Methods: A total of 76 patients (36 males and 40 females; age 44 ± s21a) were selected. Among them, 34 cases were premature ventricular contractions (VPB), 28 cases were APS (28 cases), paroxysmal supraventricular tachycardia PSVT) 14 cases, via carbamazepine 0.1g, po, tid, a total of 10d treatment. 24h before and after treatment using Holter recordings to observe the efficacy of the drug. Results: The effective rates of VPB, APB and PSVT were 74%, 79% and 93%, respectively, with less adverse reactions. Conclusions: Low-dose carbamazepine (0.3g / d) is indeed a safe and effective anti-arrhythmic drug, but it is not advisable to increase the dosage